Aetna Inc. (NYSE: AET) Stock Competitors & Peer Comparison
See AET's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AET and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AET | $106.35 | +0.00% | 0 | 9.57 | $11.12 | +1.88% |
| UNH | $407.08 | +0.77% | 369.7B | 24.91 | $16.34 | +2.18% |
| CVS | $95.70 | -0.54% | 122.1B | 12.20 | $7.84 | +2.78% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $394.20 | +0.76% | 85.5B | 13.41 | $29.39 | +1.74% |
| CI | $282.49 | +2.63% | 74.6B | 9.14 | $30.90 | +2.18% |
| HUM | $385.00 | +4.84% | 46.2B | 24.28 | $15.86 | +0.92% |
| CNC | $65.77 | +2.45% | 32.5B | 26.11 | $2.52 | N/A |
| MOH | $196.45 | +2.38% | 10.3B | 28.39 | $6.92 | N/A |
| OSCR | $27.90 | +5.12% | 7.2B | 19.93 | $1.40 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
AET vs UNH Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, UNH has a market cap of 369.7B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while UNH trades at $407.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas UNH's P/E ratio is 24.91. In terms of profitability, AET's ROE is +0.11%, compared to UNH's ROE of +0.14%. Regarding short-term risk, AET is less volatile compared to UNH. This indicates lower risk in terms of short-term price fluctuations for AET.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
AET vs CVS Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, CVS has a market cap of 122.1B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while CVS trades at $95.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas CVS's P/E ratio is 12.20. In terms of profitability, AET's ROE is +0.11%, compared to CVS's ROE of +0.06%. Regarding short-term risk, AET is less volatile compared to CVS. This indicates lower risk in terms of short-term price fluctuations for AET.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
AET vs ANTM Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas ANTM's P/E ratio is 18.99. In terms of profitability, AET's ROE is +0.11%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, AET is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for AET.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
AET vs ELV Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, ELV has a market cap of 85.5B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while ELV trades at $394.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas ELV's P/E ratio is 13.41. In terms of profitability, AET's ROE is +0.11%, compared to ELV's ROE of +0.11%. Regarding short-term risk, AET is less volatile compared to ELV. This indicates lower risk in terms of short-term price fluctuations for AET.Check ELV's competition here
Cigna Corporation (NYSE: CI)
AET vs CI Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, CI has a market cap of 74.6B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while CI trades at $282.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas CI's P/E ratio is 9.14. In terms of profitability, AET's ROE is +0.11%, compared to CI's ROE of +0.15%. Regarding short-term risk, AET is less volatile compared to CI. This indicates lower risk in terms of short-term price fluctuations for AET.Check CI's competition here
Humana Inc. (NYSE: HUM)
AET vs HUM Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, HUM has a market cap of 46.2B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while HUM trades at $385.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas HUM's P/E ratio is 24.28. In terms of profitability, AET's ROE is +0.11%, compared to HUM's ROE of +0.07%. Regarding short-term risk, AET is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for AET.Check HUM's competition here
Centene Corp. (NYSE: CNC)
AET vs CNC Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, CNC has a market cap of 32.5B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while CNC trades at $65.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas CNC's P/E ratio is 26.11. In terms of profitability, AET's ROE is +0.11%, compared to CNC's ROE of -0.24%. Regarding short-term risk, AET is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for AET.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
AET vs MOH Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, MOH has a market cap of 10.3B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while MOH trades at $196.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas MOH's P/E ratio is 28.39. In terms of profitability, AET's ROE is +0.11%, compared to MOH's ROE of -0.00%. Regarding short-term risk, AET is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for AET.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
AET vs OSCR Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, OSCR has a market cap of 7.2B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while OSCR trades at $27.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas OSCR's P/E ratio is 19.93. In terms of profitability, AET's ROE is +0.11%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, AET is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for AET.Check OSCR's competition here
Alignment Healthcare, Inc. (NASDAQ: ALHC)
AET vs ALHC Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, ALHC has a market cap of 3B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while ALHC trades at $14.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas ALHC's P/E ratio is 159.67. In terms of profitability, AET's ROE is +0.11%, compared to ALHC's ROE of +0.20%. Regarding short-term risk, AET is less volatile compared to ALHC. This indicates lower risk in terms of short-term price fluctuations for AET.Check ALHC's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
AET vs CLOV Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, CLOV has a market cap of 2.5B. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while CLOV trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas CLOV's P/E ratio is 111.63. In terms of profitability, AET's ROE is +0.11%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, AET is less volatile compared to CLOV. This indicates lower risk in terms of short-term price fluctuations for AET.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
AET vs BHG Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas BHG's P/E ratio is -0.12. In terms of profitability, AET's ROE is +0.11%, compared to BHG's ROE of +0.04%. Regarding short-term risk, AET is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for AET.Check BHG's competition here
Caring Brands, Inc. (NASDAQ: CABR)
AET vs CABR Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, CABR has a market cap of 12.1M. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while CABR trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas CABR's P/E ratio is -2.38. In terms of profitability, AET's ROE is +0.11%, compared to CABR's ROE of -3.28%. Regarding short-term risk, AET is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for AET.Check CABR's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
AET vs MGLN Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, MGLN has a market cap of 0. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas MGLN's P/E ratio is 8.49. In terms of profitability, AET's ROE is +0.11%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, AET is similarly volatile compared to MGLN. This indicates similar risk in terms of short-term price fluctuations for AET.Check MGLN's competition here
Triple-S Management Corporation (NYSE: GTS)
AET vs GTS Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, GTS has a market cap of 0. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas GTS's P/E ratio is 10.41. In terms of profitability, AET's ROE is +0.11%, compared to GTS's ROE of +0.07%. Regarding short-term risk, AET is less volatile compared to GTS. This indicates lower risk in terms of short-term price fluctuations for AET.Check GTS's competition here
Universal American Corporation (NYSE: UAM)
AET vs UAM Comparison August 2026
Aetna Inc. (NYSE: AET) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AET stands at 0. In comparison, UAM has a market cap of 0. Regarding current trading prices, AET is priced at $106.35 on the NYSE, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AET currently has a P/E ratio of 9.57, whereas UAM's P/E ratio is 1.01. In terms of profitability, AET's ROE is +0.11%, compared to UAM's ROE of +0.17%. Regarding short-term risk, AET is similarly volatile compared to UAM. This indicates similar risk in terms of short-term price fluctuations for AET.Check UAM's competition here